The mutations found in BAP1-TPDS patients affect ubiquitin carboxyl hydrolase (UCH) and nuclear localization signal (NLS) domains and create a non-functional truncated protein, disrupting BAP1 deubiquitinating activity and nuclear localization, both required for BAP1 tumor suppressor function [143]. Here, BAP1 is linked to neoplasm.